Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 15, 2026

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
14:59

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus

Published on: October 14, 2022

Pediatric gravitational shunts: initial results from a prospective study.

Regina Eymann1, Wolf-Ingo Steudel, Michael Kiefer

  • 1Department of Neurosurgery, Saarland University Medical School, Saarland, Germany. ReginaEymann@web.de

Journal of Neurosurgery
|May 1, 2007
PubMed
Summary

The Miethke Paedi-GAV shunt shows promise as a safe and effective option for pediatric hydrocephalus. Preliminary results suggest it is suitable for further randomized trials comparing pediatric shunts.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toward Trial Readiness in Congenital Myotonic Dystrophy: A Longitudinal Cohort Study of Predictors of Motor Function in Childhood.

Neurology. Genetics·2026
Same author

Measurement of Motor Function in Children With Canavan Disease: Concordance Between Remote and In-Person Assessments.

Pediatric neurology·2026
Same author

Development of German Neurosurgical Health Care from 1945 to 1955.

Journal of neurological surgery. Part A, Central European neurosurgery·2025
Same author

International Relations of German Neurosurgeons after 1945 and the Evolution of the European Association of Neurosurgical Societies.

Journal of neurological surgery. Part A, Central European neurosurgery·2025
Same author

Feasibility, Acceptability, and Reliability of Remote Motor Assessment in Children With Canavan Disease.

Pediatric neurology·2025
Same author

The Splice Index as a prognostic biomarker of strength and function in myotonic dystrophy type 1.

The Journal of clinical investigation·2025

Area of Science:

  • Neurosurgery
  • Pediatric hydrocephalus management

Background:

  • Hydrocephalus is a common neurological condition in children requiring cerebrospinal fluid (CSF) diversion.
  • Existing shunts have varying efficacy and complication rates, necessitating ongoing research into improved devices.
  • The Miethke Paedi-GAV is a novel gravitational shunt designed for pediatric use.

Purpose of the Study:

  • To prospectively evaluate the efficacy and safety of the Miethke Paedi-GAV shunt in pediatric patients.
  • To determine if the Miethke Paedi-GAV warrants inclusion in randomized controlled trials comparing pediatric shunts.

Main Methods:

  • A prospective study involving 55 children (0-6 years) undergoing primary shunt implantation with the Miethke Paedi-GAV.
  • Follow-up duration ranged from 12 to 77 months (mean 47 months).

Related Experiment Videos

Last Updated: Jul 15, 2026

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
14:59

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus

Published on: October 14, 2022

  • Primary endpoint was the first shunt failure requiring revision; complications and drainage issues were also assessed.

    • Main Results:

    • 1- and 2-year shunt survival rates were 75% and 68%, respectively.
    • The complication rate was 33%, with specific issues including underdrainage (1.8%) and overdrainage (3.6%).
    • No slitlike ventricles were observed on imaging, indicating appropriate CSF drainage.

    Conclusions:

    • The Miethke Paedi-GAV demonstrates safety and effectiveness in the pediatric population.
    • These findings support the inclusion of the Miethke Paedi-GAV in comparative randomized trials.
    • The shunt represents a potentially valuable addition to the management of pediatric hydrocephalus.